Cited by 49Nanoparticle-Based Drug DeliveryRNA Interference and Gene DeliveryNanoplatforms for cancer theranostics

Nanoparticle delivery in vivo: A fresh look from intravital imaging

Open access
Lin, Qiaoya, Fathi, Parinaz, Chen, Xiaoyuan·2020·eBioMedicine

Abstract

Nanomedicine has proven promising in preclinical studies. However, only few formulations have been successfully translated to clinical use. A thorough understanding of how nanoparticles interact with cells in vivo is essential to accelerate the clinical translation of nanomedicine. Intravital imaging is a crucial tool to reveal the mechanisms of nanoparticle transport in vivo, allowing for the development of new strategies for nanomaterial design. Here, we first review the most recent progress in using intravital imaging to answer fundamental questions about nanoparticle delivery in vivo. We then elaborate on how nanoparticles interact with different cell types and how such interactions determine the fate of nanoparticles in vivo. Lastly, we discuss ways in which the use of intravital imaging can be expanded in the future to facilitate the clinical translation of nanomedicine.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ebiom.2020.102958

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Liver-targeted delivery strategies have shown efficacy for other ion channel modulators and could be adapted to Piezo1-targeted therapies.

    “Liver-targeted delivery strategies—for instance, nanoparticle-based systems or ligand-directed conjugates—have shown efficacy for other ion channel modulators and could be adapted to Piezo1-targeted therapies.145”

    From Mechanosensitive calcium ion channels Piezo1: A therapeutic target in liver disease (2025) · cites this paper as [145]

    The section on nanoparticle–endothelial cell interactions (page unavailable) reports that melittin nanoparticles rapidly targeted liver sinusoidal endothelial cells and altered the hepatic immune environment. It does not report efficacy for ion-channel modulators or propose adapting liver-targeted delivery to Piezo1 therapies. Piezo1 appears in the supplied References passage, not as a delivery application. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lin, Q., Fathi, P., & Chen, X.
Affiliations
National Institutes of Health (US)
Corresponding author
Chen, Xiaoyuan
Venue
eBioMedicine
Publisher
Elsevier BV
Published
2020-09
Volume
59
Pages
102958
ISSN
2352-3964 (ISSN-L)
OpenAlex
W3080342211
Cited by
48
References
69
Citations by year
2026: 8 · 2025: 8 · 2024: 9 · 2023: 10 · 2022: 7 · 2021: 4 · 2020: 2
FWCI
0.39
Type
journal article
Language
en
Open access
Locations
  • EBioMedicine (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
Keywords
nanoparticle delivery, intravital imaging, nanomedicine, nanoparticle-cell interactions, nanoparticle transport, clinical translation of nanomedicine, nanomaterial design
MeSH terms
Theranostic Nanomedicine, Intravital Microscopy, Animals, Humans, Macrophages, Monocytes, Neutrophils, Permeability, Endothelial Cells, Nanoparticles, Molecular Imaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review